BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2022 12:48:56 AM | Browse: 237 | Download: 586
 |
Received |
|
2022-05-19 17:15 |
|
Peer-Review Started |
|
2022-05-19 17:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-06-09 16:23 |
|
Revised |
|
2022-06-22 18:38 |
|
Second Decision |
|
2022-08-08 03:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-18 00:12 |
|
Articles in Press |
|
2022-08-18 00:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-19 02:45 |
|
Publish the Manuscript Online |
|
2022-09-23 00:48 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapies for non-alcoholic fatty liver disease: A 2022 update
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Katie Shen, Achintya D Singh, Jamak Modaresi Esfeh and Jamile Wakim-Fleming |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Katie Shen, MD, Doctor, Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, United States. shenk2@ccf.org |
| Key Words |
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Treatment |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) is a rapidly growing epidemic with high morbidity and mortality. Although lifestyle modifications will remain a cornerstone of disease management, a multitude of therapies are under development that target different aspects of NAFLD pathogenesis. |
| Publish Date |
2022-09-23 00:48 |
| Citation |
Shen K, Singh AD, Modaresi Esfeh J, Wakim-Fleming J. Therapies for non-alcoholic fatty liver disease: A 2022 update. World J Hepatol 2022; 14(9): 1718-1729 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i9/1718.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i9.1718 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
